Kobayashi et al. [84] found that CHIT1 levels in CSF showed significant changes during nusinersen treatment in pediatric SMA patients, distinguishing it from stable inflammatory cytokines (TNF-α and INF-γ). The gene discussed is TNF; the disease is proximal spinal muscular atrophy.